Comparison · NCT01184417-901d7cd2
Phenobarbital Group vs Placebo Group: Number of Study Patients With Seizure as a Measure of Safety and Tolerability
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Phenobarbital Group vs Placebo Group: Number of Study Patients With Seizure as a Measure of Safety and Tolerability. Trial comparisons, record NCT01184417-901d7cd2. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01184417-901d7cd2
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0196 | 0.00347 | 0.103 | wilson | |
| Risk in group 2 | 0.0392 | 0.0108 | 0.132 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0196 | -0.114 | 0.0685 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.5 | 0.0468 | 5.34 | log | |
| Odds ratio, group 1 over group 2 | 0.49 | 0.043 | 5.58 | log | |
| Number needed to treat, for one fewer participant with the outcome on Phenobarbital Group than on Placebo Group | 51 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Phenobarbital Group | 10 mg/kg IV phenobarbital in 100 ml saline | 1 | 51 | OG000 |
| Group 2 | Placebo Group | 100 ml saline | 2 | 51 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Study Patients With Seizure as a Measure of Safety and Tolerability
- Description
- Did the study patient have a witnessed seizure during their hospitaliztion (yes/no).
- Time frame
- 1 year
- Population
Source ClinicalTrials.gov
Trial
- Title
- Phenobarbital for Acute Alcohol Withdrawal
- NCT number
- NCT01184417
- Phases
- NA
- Conditions
- Alcohol Withdrawal
- Interventions
- 10 mg/kg IV phenobarbital in 100 ml saline, placebo
- Lead sponsor
- Jonathan Rosenson
- Results first posted
- 2012-03-09
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01184417?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01184417-901d7cd2